*Applications will be reviewed on a rolling-basis.
A postdoctoral fellowship opportunity is currently available in the Division of Systems Biology, National Center for Toxicological Research (NCTR) of the U.S. Food and Drug Administration (FDA) Jefferson Laboratories Campus located in Jefferson, Arkansas, with a joint research station at the University of Tennessee Health Science Center (UTHSC) Regional Biocontainment Laboratory (RBL) in Memphis, Tennessee.
Research efforts will include participation in multi-disciplinary efforts in a nationally recognized training program in support of the FDA’s mission. The participant will use a combination of pathological and toxicological approaches to evaluate potential effects of SARS-CoV-2 infection and therapeutic administration in a COVID-19 animal model during pregnancy and during development. S/he will have dual research stations at the UTHSC RBL in Memphis, TN, and the FDA NCTR campus in Jefferson, AR. S/he will be expected to collaborate with FDA investigators at NCTR, with investigators at UTHSC, and with investigators in other FDA Centers/Offices. During the project, s/he will be actively encouraged to present the research at internal and external meetings and publish the findings in peer-reviewed journals.
Anticipated Appointment Start Date: ~February 2021
If you have questions, send an email to ORISE.FDA.NCTR@orau.org. Please include the reference code for this opportunity (FDA-NCTR-2021-0004) in your email.